Armstrong Fleming & Moore’s Merck MRK Stock Holding History

Armstrong Fleming & Moore’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Hold	8,188	–	–	0.35%	41
2026 Q1	$985K	Buy	8,188 +250	+3%	+$28.9K	0.42%	40
2025 Q4	$836K	Hold	7,938	–	–	0.39%	40
2025 Q3	$666K	Hold	7,938	–	–	0.32%	50
2025 Q2	$628K	Buy	+7,938	New	+$631K	0.34%	48
2025 Q1	–	Sell	-7,437	Closed	-$740K	–	129
2024 Q4	$740K	Sell	7,437 -525	-7%	-$54.1K	0.45%	39
2024 Q3	$904K	Hold	7,962	–	–	0.53%	36
2024 Q2	$986K	Hold	7,962	–	–	0.63%	30
2024 Q1	$1.05M	Buy	7,962 +1	+0%	+$123	0.73%	27
2023 Q4	$868K	Sell	7,961 -97	-1%	-$10.1K	0.65%	33
2023 Q3	$830K	Sell	8,058 -385	-5%	-$41.5K	0.8%	30
2023 Q2	$974K	Buy	+8,443	New	+$959K	0.9%	29

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Armstrong Fleming & Moore's MRK Position: Q2 2026 in Review

Armstrong Fleming & Moore held its Merck (MRK) position steady in Q2 2026 at 8,188 shares worth $1.05M. The position accounts for 0.35% of the portfolio, ranked #41.

Armstrong Fleming & Moore first reported a position in MRK in Q2 2023 and has held it in 12 quarters since. 3,832 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Armstrong Fleming & Moore held 8,188 shares of Merck worth $1.05M as of Q2 2026.
Armstrong Fleming & Moore left its Merck share count unchanged in Q2 2026.
Merck made up 0.35% of Armstrong Fleming & Moore's portfolio in Q2 2026, its #41 holding.
Armstrong Fleming & Moore first reported a position in Merck in Q2 2023 and has held it in 12 quarters since.
3,832 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Armstrong Fleming & Moore's 13F filing for Q2 2026, filed 28 Jul 2026.